Amrutanjan Health Care Yönetim
Yönetim kriter kontrolleri 2/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Sambhu Sivalenka
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | 25.8yrs |
| CEO sahipliği | 13.9% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 3.4yrs |
Son yönetim güncellemeleri
Recent updates
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹426m |
| Mar 31 2024 | n/a | n/a | ₹450m |
| Dec 31 2023 | n/a | n/a | ₹440m |
| Sep 30 2023 | n/a | n/a | ₹373m |
| Jun 30 2023 | n/a | n/a | ₹432m |
| Mar 31 2023 | n/a | n/a | ₹398m |
| Dec 31 2022 | n/a | n/a | ₹418m |
| Sep 30 2022 | n/a | n/a | ₹517m |
| Jun 30 2022 | n/a | n/a | ₹588m |
| Mar 31 2022 | n/a | n/a | ₹672m |
| Dec 31 2021 | n/a | n/a | ₹627m |
| Sep 30 2021 | n/a | n/a | ₹631m |
| Jun 30 2021 | n/a | n/a | ₹668m |
| Mar 31 2021 | n/a | n/a | ₹612m |
| Dec 31 2020 | n/a | n/a | ₹589m |
| Sep 30 2020 | n/a | n/a | ₹474m |
| Jun 30 2020 | n/a | n/a | ₹322m |
| Mar 31 2020 | ₹13m | ₹11m | ₹251m |
| Dec 31 2019 | n/a | n/a | ₹314m |
| Sep 30 2019 | n/a | n/a | ₹274m |
| Jun 30 2019 | n/a | n/a | ₹257m |
| Mar 31 2019 | ₹13m | ₹11m | ₹250m |
| Dec 31 2018 | n/a | n/a | ₹158m |
| Sep 30 2018 | n/a | n/a | ₹168m |
| Jun 30 2018 | n/a | n/a | ₹201m |
| Mar 31 2018 | ₹13m | ₹11m | ₹200m |
Tazminat ve Piyasa: Sambhu şirketinin toplam tazminatının Indian pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.
Tazminat ve Kazançlar: Sambhu 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Sambhu Sivalenka (50 yo)
25.8yrs
Görev süresi
₹12,759,000
Tazminat
Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Executive Chairman since February 13, 2012. He has been Director...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman & MD | 25.8yrs | ₹12.76m | 13.94% ₹ 2.9b | |
| Non-Executive Independent Director | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | 3.5yrs | ₹1.95m | Veri yok | |
| Non-Executive Non Independent Director | 1.4yrs | ₹1.12m | 7.76% ₹ 1.6b | |
| Non-Executive & Non Independent Director | 9.5yrs | ₹1.50m | 0.12% ₹ 25.6m | |
| Non-Executive Independent Director | 3.4yrs | ₹2.07m | Veri yok | |
| Additional Non-Executive Independent Director | 2.3yrs | ₹1.49m | Veri yok |
3.4yrs
Ortalama Görev Süresi
65yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: AMRUTANJAN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).